Clinical pharmacology considerations for children supported with ventricular assist devices
Jennifer Sherwin(Duke Medical Center), Christoph P. Hornik(Duke University), Kevin Watt(University of Utah), Daniel González(University of North Carolina at Chapel Hill), Andrew J. Lodge(Duke Medical Center), Kevin D. Hill(Duke University), Elizabeth J. Thompson(University of North Carolina at Chapel Hill)
Cited by 5
Related Papers
Significance of Protein Binding in Pharmacokinetics and Pharmacodynamics
|Journal of Pharmaceutical Sciences|2009|337
A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study)
|Clinical Infectious Diseases|2020|232
Selection of Antiobesity Medications Based on Phenotypes Enhances Weight Loss: A Pragmatic Trial in an Obesity Clinic
|Obesity|2021|199
Gestational Age at Birth and Outcomes After Neonatal Cardiac Surgery
|Circulation|2014|197
Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing
|Clinical Therapeutics|2016|170